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A Rare Case of Recurrent Myoid
Hamartoma Mimicking Malignancy:
Imaging Appearances
Myoid hamartoma is an uncommon type of breast hamartoma and its recur-
rence is very rare. We report the imaging appearance of an unusual case of
recurrent myoid hamartoma of the breast mimicking malignancy in a 43-year-old
woman. Although the mammographic and ultrasonographic findings have long
been described in the literature, MR finding with a dynamic study has not, to the
best of our knowledge, been reported previously.
reast hamartomas are rare breast neoplasms, with the main characteristic
being the various tissues they contain. Histologically, breast hamartomas
have been classified as various types based on the predominant type of
tissue, which include fibrous, fibrocystic, and fibroadenomatous tissue with adipose
tissue. Myoid hamartoma which has smooth muscle cells is a rare type (1). As the
recurrence of a myoid hamartoma is very rare, we report a patient with recurrent
myoid hamartoma of the breast, describe the radiologic findings including MR, and
review the relevant literature.  
CASE REPORT
A 43-year-old woman had undergone surgery for a myoid hamartoma in the lower
outer quadrant of the patient’s left breast. Twelve months later, she presented with a
palpable lump under the surgical scar. A clinical breast examination revealed a 3.0-cm
sized firm mass with slight mobility under the scar. A mammography showed two oval
isodense masses with a partially obscured margin in the left subareolar area (Fig. 1A).
Ultrasound images showed a 2.3-cm sized irregular isoechoic mass with a microlobu-
lated margin situated in the surgical bed (Fig. 1B). Another 2.0-cm sized, oval
hypoechoic mass with a circumscribed margin was found in the lower outer quadrant
of the patient’s left breast (Fig. 1C). US examination results indicated that the mass in
the surgical bed was considered to be suspicious. To further evaluate the suspicious
mass, MRI was performed on a 1.5 Tesla system (General Electric Medical Systems,
Milwaukee, WI) with a specially developed double breast coil. The MR revealed two,
circumscribed, oval-shaped masses which appeared to be of isosignal intensity relative
to skeletal muscle on the T1-weighted images (WI) and with high-signal intensity on
the T2-WI. On contrast enhanced T1-WI and subtracted images, the masses showed
strong enhancement. On dynamic MRI, the mass situated in the surgical bed showed
early intense enhancement and progressive signal loss over time (Fig. 1D, E). This
finding was considered to be suspicious for malignancy. The lesion found in the lower
outer quadrant of the left breast showed progressive enhancement (Fig. 1F, G) and
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Bthought to be benign.
A 14-gauge core needle biopsy was performed on the
mass under the scar using ultrasound guidance. A
microscopic evaluation revealed that the lobules and ducts
of the mammary gland and stroma had no malignant
component and reported to be a fibroadenoma. The
patient requested and then underwent a surgical excision
in order to obtain a definitive diagnosis. The gross pathol-
ogy evaluation of the specimen revealed a 2.5×1.8×2.0-
cm-long rubbery, white, solid mass situated in the surgical
bed and a 2.3×1.4×2.4-cm-long rubbery, white, solid
mass in the lower outer quadrant of the left breast; both
masses were round and had smooth margins.  The
microscopic evaluation of the mass situated in the surgical
bed revealed lobules and ducts of the mammary gland,
stroma with a high collagen concentration, and many
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Fig. 1. 43-year-old female patient.
A. Medio-lateral oblique view of left breast shows two oval isodense masses (arrows and arrowheads) with partially obscured margin
(arrows) in left subareolar area.
B, C. Ultrasound images show 2.3-cm sized irregular isoechoic mass (white arrowheads) with microlobulated margin located between
surgical scars (arrows) and overlying skin scar (black star B), and another, 2.0-cm sized oval hypoechoic mass with circumscribed
margin located in lower outer quadrant of left breast (C).
D. Contrast-enhanced sagittal subtracted MR image reveals rapidly enhancing mass.
CDbundles of smooth muscle fiber without atypia (Fig. 1H).
An immunohistochemical investigation was positive for
vimentin, smooth muscle actin, CD34 in the smooth
muscle cells, but negative for S100 protein. The final
pathology diagnosis was myoid hamartoma, whereas the
other mass was a fibroadenoma.
DISCUSSION
Breast hamartomas consist of approximately 0.7-5% of
all benign breast tumors (2). They are rare benign breast
neoplasms consisting of a disorganized overgrowth of
normal breast tissue. Breast hamartomas are usually classi-
fied subtypes based on the predominant tissue. Myoid
hamartoma is a rare hamartoma subtype characterized by
the presence of histologically normal, but irregular,
randomly distributed, smooth muscle cells (3). 
There are several theories regarding the origin of smooth
muscle cells (3, 4), which include that muscle cells originate
from stroma via leiomyomatous metaplasia, local vessel
Recurrent Myoid Hamartoma Mimicking Malignancy
Korean J Radiol 11(6), Nov/Dec 2010 685
EG
Fig. 1. 43-year-old female patient.
E. Graph of MRI time-signal intensity curves from MR image shows rapid enhancement on first postcontrast time point and significant
drop in signal on subsequent time points.
F. Contrast-enhanced sagittal subtracted MR image reveals progressive enhancement of mass.
G. Graph of MRI time-signal intensity curves from MR image shows gradual enhancement on first postcontrast time point and continuous
increase in signal on subsequent time points.
H. Photomicrograph shows smooth muscle fibers without atypia (Hematoxylin & Eosin stain, ×100). 
FHwalls, or myoepithelium via a metaplastic process.
A mammography usually shows a well-circumscribed
mass with a radiolucent area, suggestive of fat tissue, and
sometimes a thin capsule (5). Ultrasound often shows well-
circumscribed masses of heterogeneous density and
ranging from hypoechoic to hyperechoic (6).
Although breast hamartoma has long been described in
the literature, there have been only a few descriptions of
their MR appearance (7). A previous report demonstrates
the MR characteristics of a hamartoma that had a high
signal on T1WI and in which the moderate signal seen on
T2WI corresponded to the fatty component of the mass.
However, in this case, the myoid hamartoma showed no
high signal on T1WI and showed early intense enhance-
ment and progressive signal loss over time (washout) on
dynamic MRI, which suggested malignancy (7). Therefore,
arriving at a differential diagnosis from malignancy was
difficult in this case. The fibroadenoma showed progressive
enhancement, which made it more likely to be benign (7). 
A core biopsy may be diagnostic for a myoid
hamartoma, although a subsequent excisional biopsy and
immunohistochemical evaluation ensure the definite
diagnosis of a breast hamartoma (8). Microscopically,
smooth muscle cell, fibrous stroma, and adipose tissue are
evident. The immunohistochemistry examination revealed
that the findings were positive for the presence of smooth
muscle actin, desmin, as well as vimentin, and negative for
S-100 protein (3).  
Local excision is the treatment of choice for a myoid
hamartoma, and no adjuvant therapy is needed following
surgery. Although there are no data regarding the tumor
recurrence rate, reported cases of tumor recurrence are
very rare with only one case having been reported by
Linell et al. (9). Our patient experienced recurrence is 12
months.
In conclusion, we have presented a rare case of recurrent
myoid hamartoma in which the MR features mimicked
malignancy.
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